Limited recent data exist on prescribing patterns and patient characteristics for GLP-1 RA medications, whether used as anti-diabetic medication (ADM) for patients with type 2 diabetes (T2D) and/or used as an anti-obesity medication (AOM) for patients with overweight or obesity
Major challenges in this method include maintaining stability and compatibility of multiple agents, avoiding unwanted interaction, and optimizing pharmacokinetics and pharmacodynamics
Chemically, the effects may vary among different patient groups, but theres also a dopaminergic component: dopamine, a hormone released in the brain in response to stimuli, may decrease when using these peptides
The protocol comes after not before that conversation
Why have our general medical doctors become mired in treatment for depression, anxiety, bipolar, PTSD, etc., when their training does in no way cover these aspects of human health, or how to assess, address or successfully resolve them
W momencie odkadania hantli usyszaem i poczuem charakterystyczne "wystrzelenie" w kolanach
